Allura Red AC: Why SCCS and EFSA Safety Records Diverge
Allura Red AC has SCCS and EFSA no-observed values that differ for the same CAS, species, route, and unit in the cross-vertical finding.
Allura Red AC is flagged in the cross-vertical regulatory-gap output because the same CAS record (25956-17-6) has different no-observed values in SCCS-family and EFSA source records. The lead row compares rat oral data in mg/kg bw/day.
| Species | Route | Unit | EFSA value | SCCS-family value | Ratio |
|---|---|---|---|---|---|
| rat | oral | mg/kg bw/day | 695 | 3750 | 5.4x |
| rat | oral | mg/kg bw/day | 701 | 3750 | 5.35x |
What Each Source Says
The EFSA-side value in the lead row is 695 mg/kg bw/day. The SCCS-family value in the same matched comparison is 3750 mg/kg bw/day. The finding states that the EFSA no-observed value is lower than the SCCS-family no-observed value for the same CAS, species, route, and unit.
That match condition is important. This is not a broad statement that every safety endpoint for Allura Red AC disagrees. The finding is narrower and stronger: the comparison holds within the normalized species, route, and unit keys shown in the table.
Why It Matters for Formulators
For cosmetic formulation, the SCCS-family record is the more directly cosmetic source. EFSA data, however, can still matter when the same chemical identity appears across food, pesticide, or other exposure contexts. A lower EFSA no-observed value does not automatically rewrite a cosmetic opinion, but it does mark a substance that deserves careful source-by-source review.
The practical takeaway is to avoid collapsing all NOAEL values for Allura Red AC into a single number. The source corpus, study type, species, route, and endpoint context all carry weight. A one-number summary would hide the divergence that makes this substance worth checking.
What Not to Infer
This divergence row is not a standalone ban, approval, or reformulation deadline. It is a source-comparison signal. The correct inference is narrower: for Allura Red AC, one matched EFSA no-observed value is lower than one or more matched SCCS-family values under the same normalized comparison keys. That is enough to justify review, but not enough to replace the underlying source documents.
The page is therefore useful as a map, not a verdict. It points to the precise mismatch a reviewer should investigate: chemical identity, endpoint value, route, species, unit, and source corpus. Those details are the difference between a real regulatory divergence story and a vague claim that two authorities disagree.
If a brand is using Allura Red AC globally, this kind of cross-source mismatch is where review time should go first. A single cosmetic formulation may be legal and still deserve a closer toxicology note when another major source corpus reports a lower point of departure for a matched comparison.
The safest editorial wording is therefore specific: this page compares records, not countries. The source labels, values, and normalized matching keys are shown so the claim stays tied to the evidence that created the divergence flag.
Audit Handle
Lead finding ratio: 5.4x. CAS: 25956-17-6. Sources: EFSA and SCCS-family records.
Next Read
Use the Allura Red AC ingredient page for substance identity and cross-source profile, then trace the SCCS or EFSA source records listed below for the exact study-level wording.
Source
- Cross-vertical finding: query1_regulatory_gaps.json
- src_corpus: EFSA; source: EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx; src_file: Source documentation archived. reference: EFSA ANS - 2009 - OutputID 391 - growth - developmental - Scientific Opinion on the re-evaluation of Allura Red AC (E 129) as a food additive - doi:10.2903/j.efsa.2009.1327
- src_corpus: SCCNFP; source: SCCNFP_vision_codex; src_file: out264_en.pdf; reference: {"citation":"Ref.: 2 Rat Groups of 6 male rats were fed 0 or 5","dose":"Based on this study administering 5 % Curry Red in the diet (equals about 3750 mg/kg bw/day, assuming an average bodyweight of 200 g and a food con.